-transparent.png){kind=logo}
Novel spirooxindole-pyrrolidine compounds have been synthesised through 1,3-dipolar cycloaddition of azomethine ylides generated from isatin and sarcosine or thioproline with the dipolarophile 3-(1H-imidazol-2-yl)-2-(1H-indole-3-carbonyl)acrylonitrile under the optimised reaction condition. Synthesised compounds were evaluated for their anticancer activity against A549 human lung adenocarcinoma cancer cell line. Among the 29 tested compounds 4j, 6b and 6h showed very high activity 66.3%, 64.8% and 66.3% at 25 μg/mL concentration against A549 lung adenocarcinoma cancer cell line. These spirooxindole-pyrrolidine compounds can be promising therapeutic agents for A549 lung adenocarcinoma cancer cell line.
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
June 2023,
ACS omega,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
January 2021,
Bioorganic chemistry,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
February 2019,
Bioorganic chemistry,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
August 2023,
Chemical biology & drug design,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
July 2023,
ACS omega,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
December 2020,
Archiv der Pharmazie,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
December 2016,
Journal of photochemistry and photobiology. B, Biology,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
January 2022,
Anti-cancer agents in medicinal chemistry,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
June 2023,
Molecular diversity,
Y Arun, and
K Saranraj, and
C Balachandran, and
P T Perumal
September 2022,
Molecules (Basel, Switzerland),
